Meta ‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer

In conclusion, the currently available evidence shows that WBRT plus TMZ increases the overall response rate in patients with brain metastases of NSCLC compared with WBRT alone. The currently available evidence shows that whole‐brain radiotherapy (WBRT) plus temozolomide increases the overall response rate in patients with brain metastases of non‐small‐cell lung cancer compared with WBRT alone.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: Original Research Source Type: research